Literature DB >> 423183

Syntheses and antiinflammatory actions of 4,5,6,7-tetrahydroindazole-5-carboxylic acids.

M Nagakura, T Ota, N Shimidzu, K Kawamura, Y Eto, Y Wada.   

Abstract

A novel series of 1-aryl-4,5,6,7-tetrahydro-1H-indazole-5-carboxylic acids and 2-aryl-4,5,6,7-tetrahydro-2H-indazole-5-carboxylic acids were synthesized via condensation between a phenylhydrazine and a 2-(hydroxymethylene)cyclohexanone-4-carboxylate, and the antiinflammatory activity was determined. In the carrageenan edema test, 1-aryl-4,5,6,7-tetrahydro-1H-indazole-5-carboxylic acids exhibited fairly high antiinflammatory activity. However, the 2-aryl isomers were far less active than the former. The most active compound of the series was 1-phenyl-4,5,6,7-tetrahydro-1H-indazole-5-carboxylic acid, which had an ED50 value of 3.5 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 423183     DOI: 10.1021/jm00187a012

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation.

Authors:  Carlo Ballatore; Kurt R Brunden; Francesco Piscitelli; Michael J James; Alex Crowe; Yuemang Yao; Edward Hyde; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

2.  Aminothienopyridazine inhibitors of tau aggregation: evaluation of structure-activity relationship leads to selection of candidates with desirable in vivo properties.

Authors:  Carlo Ballatore; Alex Crowe; Francesco Piscitelli; Michael James; Kevin Lou; Gabrielle Rossidivito; Yuemang Yao; John Q Trojanowski; Virginia M-Y Lee; Kurt R Brunden; Amos B Smith
Journal:  Bioorg Med Chem       Date:  2012-05-23       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.